1. Academic Validation
  2. Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

  • Nat Struct Mol Biol. 2012 Nov;19(11):1139-46. doi: 10.1038/nsmb.2390.
Etienne Dardenne 1 Sandra Pierredon Keltouma Driouch Lise Gratadou Magali Lacroix-Triki Micaela Polay Espinoza Eleonora Zonta Sophie Germann Hussein Mortada Jean-Philippe Villemin Martin Dutertre Rosette Lidereau Stéphan Vagner Didier Auboeuf
Affiliations

Affiliation

  • 1 Institut National de la Santé et de la Recherche Médicale, U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Abstract

Both epigenetic and splicing regulation contribute to tumor progression, but the potential links between these two levels of gene-expression regulation in pathogenesis are not well understood. Here, we report that the mouse and human RNA helicases Ddx17 and Ddx5 contribute to tumor-cell invasiveness by regulating alternative splicing of several DNA- and chromatin-binding factors, including the macroH2A1 histone. We show that macroH2A1 splicing isoforms differentially regulate the transcription of a set of genes involved in redox metabolism. In particular, the SOD3 gene that encodes the extracellular superoxide dismutase and plays a part in cell migration is regulated in an opposite manner by macroH2A1 splicing isoforms. These findings reveal a new regulatory pathway in which splicing factors control the expression of histone variant isoforms that in turn drive a transcription program to switch tumor cells to an invasive phenotype.

Figures